Sir, Basal cell carcinoma (BCC) is a malignant neoplasm of abnormal folliculosebaceous-apocrine germinative cells, constituting approximately 70% of all keratinocyte tumors. It commonly affects the head and neck region. [1] BCC with sebaceous differentiation is a rare histopathological variant. [2, 3] A 42-year-old male presented with a solitary asymptomatic nodular swelling having erosion and crusting of the overlying skin close to the left nasolabial fold. There was history of a small pigmented lesion at the same site since childhood, which had increased in size with change in appearance for the last 3 months. He was a known hypertensive for the past 10 years and was on medication for the same. His medical history was otherwise unremarkable.
Cutaneous examination revealed a skin-colored nodule of 1 cm × 1.5 cm in size just below the left nasolabial fold with overlying crusting and telangiectasia [ Figure 1 ]. Considering the morphology of the lesion, differential diagnoses of nodular BCC and keratoacanthoma were considered. Skin biopsy from the nodular lesion revealed the presence of poorly circumscribed tumor masses in the dermis with peripheral palisading of basaloid cells along with retraction artefacts. Higher magnification revealed nodular collection of basaloid cells separated by fibrous septae. These nodules contained tubular laminae lined by cornified cells having a crenulated inner surface as well as sebaceous differentiation with the presence of sebocytes. 
Basal Cell Carcinoma with Sebaceous Differentiation
BCC is a malignant neoplasm derived from abnormal folliculosebaceous-apocrine germinative cells. [] BCC with sebaceous differentiation is a rare presenatation with very few reports. [2] Histopathological examination of a BCC with sebaceous differentiation usually reveals poorly circumscribed neoplasm invading the deep dermis composed of columnar basaloid cells having slightly elongated nuclei aligned in a palisade at the periphery, retraction clefts between the stroma and tumor aggregates, and sebaceous duct-like structures. Vacuolated cells, with foamy, bubbly cytoplasm and scalloped or starry nuclei, suggestive of sebocytes are scattered within the tumor masses. These vacuolated cells are immunohistochemically positive for epithelial membrane antigen (EMA). [4] The criteria for the diagnosis of this tumor are variably defined by various authors. BCC with sebaceous differentiation is differentiated from sebaceous adenoma by a germinative cell component which occupies greater than 50% of the transverse diameter of tumor lobules that typically manifest a rounded morphology with areas of slit-like retraction and accompanied by mitoses and apoptotic debris. Unlike sebaceous carcinoma, there is no evidence of pagetoid spread in the overlying epidermis, haphazard infiltrative growth morphology, desmoplastic stromal reaction, and invasion of adjacent structures.
In constrast, sebaceous adenoma is characterized by a lining of germinative cells less than 50% of the diameter of the neoplastic lobule whereas sebaceous hyperplasia typically has a peripherally disposed layer of germinative cells, typically 1-2 cells thick. On the other hand, sebaceoma manifests a haphazard array of germinative epithelium admixed with sebocytes and structures that recapitulate sebaceous ducts. [5] Differentiating features between BCC with sebaceous differentiation, sebaceoma, and sebaceous carcinoma are listed in Table 1 . [1,2,-6-10] BCC is a malignant neoplasm with rare variants of apocrine or follicular or sebaceous differentiation. [4] The rarity of BCC with sebaceous differentiation may be attributed to the ambiguous nomenclature of sebaceous neoplasms in the past and low awareness about this presentation. BCC with sebaceous differentaition usually does not have an adverse prognosis.
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The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Patients with PV had significantly longer P-max duration than healthy controls [P < 0.0001, Figure 1 ]. However, two groups were similar in the P-min durations [P = 0.07, Figure 2 ]. Compared to control group, patients had significantly greater PWD [P < 0.0001, Figure 3 ]. No association was observed between PWD with regards Sir, Mortality rate among pemphigus vulgaris (PV) patients is higher than general population. Coronary heart disease and cardiac arrhythmia have a statistically significant association with mortality in PV patients. [1] P-wave duration and P-wave dispersion (PWD) are important electrocardiogram (ECG) markers used to evaluate the risk of atrial arrhythmias. Some studies have shown that PWD has a predictive value for atrial fibrillation (AF) in patients with inflammatory conditions such as rheumatoid arthritis, scleroderma, and inflammatory bowel disease. [2] [3] [4] We performed a case-control study to investigate the risk of AF in PV patients through ECG markers.
Forty-five PV patients and 45 healthy age-and sexmatched controls were included in the study. The patients fulfilled the currently accepted criteria for PV, defined as the presence of typical mucocutaneous lesions confirmed by pathology and direct immunofluorescence (Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, 2014-2016).
Patients and control subjects with cardiopulmonary diseases, obesity (body mass index ≥30 kg/m 2 ), hypertension, hyperlipidemia, and diabetes mellitus were excluded from the study. Cardiopulmonary dysfunction was excluded by echocardiography. Biochemical variables such as fasting glucose levels and lipid panel were analyzed. All provided written informed consent for inclusion in How to cite this article: Save S, Tambe S, Nayak C. Basal cell carcinoma with sebaceous differentiation. Indian Dermatol Online J 2018;9:273-5.
